Senior management promotions at Rib-X
This article was originally published in Scrip
Rib-X Pharmaceuticals, a development-stage company with a pipeline of broad spectrum antibiotics, has promoted Dr Erin Duffy to chief scientific officer and Jarrod Longcor to vice-president of corporate development. Dr Duffy joined Rib-X in 2002 and previously served as the company's vice-president of discovery research. Mr Longcor has served the company since 2007 and previously served as senior director of business development.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.